{{Rsnum
|rsid=2274316
|Gene=MEF2D
|Chromosome=1
|position=156476450
|Orientation=plus
|GMAF=0.4307
|Gene_s=MEF2D
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 41.6 | 48.7 | 9.7
| HCB | 42.3 | 48.2 | 9.5
| JPT | 57.5 | 34.5 | 8.0
| YRI | 3.4 | 33.3 | 63.3
| ASW | 10.5 | 43.9 | 45.6
| CHB | 42.3 | 48.2 | 9.5
| CHD | 45.4 | 46.3 | 8.3
| GIH | 44.6 | 45.5 | 9.9
| LWK | 8.2 | 33.6 | 58.2
| MEX | 31.0 | 44.8 | 24.1
| MKK | 21.8 | 53.8 | 24.4
| TSI | 52.0 | 38.2 | 9.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23793025
  |Trait=Migraine
  |Title=Genome-wide meta-analysis identifies new susceptibility loci for migraine.
  |RiskAllele=C
  |Pval=1E-8
  |OR=1.07
  |ORtxt=[1.05-1.10]
  }}

{{PMID Auto
|PMID=24674449
|Title=A replication study of GWAS findings in migraine identifies association in a Swedish case-control sample
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}